SAN DIEGO , Feb. 27, 2014 /PRNewswire/ -- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim ® Insulin Pump, plans to release its fourth quarter and full year 2013 financial results after the financial markets close on Thursday, March 6 , 2014. 

SAN DIEGO , Feb. 6, 2014 /PRNewswire/ --  Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today presented the results of a research study that demonstrated faster training times and fewer errors when using the t:slim Pump versus a

SAN DIEGO , Jan. 29, 2014 /PRNewswire/ --   Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that Kim Blickenstaff , president and CEO, will present a company update at the Leerink Global Healthcare Conference in New

Company Is Providing Replacement Cartridges to Its Customers at No Additional Charge

Company Is Providing Replacement Cartridges to Its Customers at No Additional Charge

SAN DIEGO , Dec. 20, 2013 /PRNewswire/ -- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim ® Insulin Pump, today announced that the company was added to the Russell 2000® and Russell 3000® Indexes following reconstitution of Russell Investment

SAN DIEGO , Nov. 19, 2013 /PRNewswire/ -- Tandem Diabetes Care reg;, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim ® Insulin Pump, today announced the closing of its initial public offering of 9,200,000 shares of common stock at a price of $15.00 per share, which

SAN DIEGO, Nov. 15, 2013 /PRNewswire/ -- Tandem Diabetes Care®, Inc. ("Tandem"), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that the underwriters of its previously announced initial public offering of common stock have exercised their option to purchase

SAN DIEGO, Nov. 13, 2013 /PRNewswire/ -- Tandem Diabetes Care®, Inc. ("Tandem"), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced the pricing of its initial public offering of 8,000,000 shares of common stock at a price of $15.00 per share.

SAN DIEGO, CA, October 07, 2013 Tandem Diabetes Care®, Inc. ("Tandem") a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of

SAN DIEGO, CA, September 30, 2013 Tandem Diabetes Care®, Inc. (“Tandem”) today announced  that its t:slim® Insulin Pump has been selected as a finalist in the Life Sciences – Medical Products category for the 2013 Most Innovative New Product Awards, sponsored by CONNECT.  The t:slim Pump is the

Tandem Diabetes Care Sponsors "Greatest Awards Show in Diabetes" SAN DIEGO, CA, August 13, 2013 Tandem Diabetes Care®, Inc. ("Tandem") announced today that it is the Presenting Sponsor of The Greatest Awards Show in Diabetes, presented by Insulindependence (IN), a nonprofit organization dedicated

SAN DIEGO, CA, June 20, 2013 Tandem Diabetes Care®, Inc. (“Tandem”) today announced that its t:slim® Insulin Pump was chosen as the Readers’ Choice for Most Innovative Product at the 2013 Medical Design Excellence Awards held in Philadelphia, PA on June 19, 2013.

SAN DIEGO, CA, April 02, 2013 Tandem Diabetes Care ® , Inc. (“Tandem”) today announced that the t:slim® Insulin Pump has been selected as a finalist in the 15th Annual Medical Design Excellence Awards competition. The t:slim Pump is the first touchscreen insulin pump for people with diabetes and

Tandem Diabetes Care Announces FDA Clearance of t:connect Diabetes Management Application for Use with t:slim Insulin Pump SAN DIEGO, CA, February 26, 2013 Tandem Diabetes Care ® , Inc. (“Tandem”) today announced that its t:connect™ Diabetes Management Application, the web-based data management

Tandem Diabetes Care Names Lonnie Smith as Chairman of the Board SAN DIEGO, CA, February 20, 2013 Tandem Diabetes Care, Inc. (“Tandem”) today announced the appointment of Lonnie Smith as Chairman of its Board of Directors. Mr. Smith is Chairman of the Board and former chief executive officer of

Tandem Diabetes Care Acquires Select Patents and Patent Applications from Smiths Medical SAN DIEGO, CA, February 01, 2013 Tandem Diabetes Care, Inc. (“Tandem”) announced today that it has acquired ownership from Smiths Medical ASD, Inc. of over 23 U.S.

Tandem Diabetes Care Announces Partnership with JDRF to Develop a Novel Dual-Chamber Infusion Pump SAN DIEGO, CA, January 08, 2013 Tandem Diabetes Care, Inc. (“Tandem”) announced today a partnership with JDRF, the leading global organization focused on type 1 diabetes (T1D) research, to develop a

Tandem Diabetes Care and Dexcom Expand Development and Commercialization Agreement to Include Recently Approved G4™ PLATINUM CGM Sensor SAN DIEGO, CA, January 08, 2013 Tandem Diabetes Care, Inc. (“Tandem”) announced today that its Development and Commercialization Agreement with Dexcom, Inc., has

Tandem Diabetes Care Awarded CHAP Accreditation SAN DIEGO, CA, August 01, 2012 Community Health Accreditation Program, Inc., (CHAP) announced today that Tandem Diabetes Care, Inc. has been awarded CHAP accreditation under the CHAP Standards of Excellence.